Condition (MeSH)
Retinal Artery Occlusion
ClinicalTrials.gov lists 34 trials for Retinal Artery Occlusion or a narrower condition beneath it. Fondation Ophtalmologique Adolphe de Rothschild has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
30 of the 34 trials are tagged with Retinal Artery Occlusion itself; the rest are tagged with a narrower condition beneath it.
When did Retinal Artery Occlusion trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 3 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 34 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Retinal Artery Occlusion trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 4 |
| Phase 4 | 1 |
| Not applicable | 10 |
| Observational | 17 |
How many Retinal Artery Occlusion trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 6 |
| Completed | 16 |
| Terminated | 4 |
| Unknown status | 7 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Retinal Artery Occlusion trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Fondation Ophtalmologique Adolphe de Rothschild | 2 |
| Kyoto Drug Discovery and Development Co., Ltd. | 1 |
Which drugs are being tested for Retinal Artery Occlusion? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Regadenoson | 1 |
| Tenecteplase | 1 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| EC Aspirin | 2 |
| KUS121 low dose | 1 |
| KUS121 high dose | 1 |
| Topical use of beta-blocker | 1 |
| Acetazolamide Pill | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Retinal Artery Occlusion? (40)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion. | The New England journal of medicine | 2026 | Yes |
| Early reperfusion in patients with acute retinal artery occlusion: A multicenter prospective study. | International journal of stroke : official journal of the International Stroke Society | 2025 | Yes |
| Self-reported health status of patients with acute retinal ischemia and stroke related hemianopia. | European stroke journal | 2025 | Yes |
| Artificial Intelligence-Based Detection of Central Retinal Artery Occlusion Within 4.5 Hours on Standard Fundus Photographs. | Journal of the American Heart Association | 2025 | Yes |
| Manual measurement of SD-OCT images of hyperreflective retinal layers in acute retinal vessel occlusion is reliable, repeatable and reproducible. | Scientific reports | 2025 | Yes |
Showing 5 of 40 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.